Education
About Us
Working with TipRanks
Follow Us
Twist Bioscience (TWST)
:TWST
TWST Stock Chart & Stats
$26.00
-$0.78(-1.71%)
At close: 4:00 PM EST
$26.00
-$0.78(-1.71%)
Day’s Range― - ―
52-Week Range$23.30 - $55.33
Previous CloseN/A
Volume152.02K
Average Volume (3M)1.62M
Market Cap
$1.98B
Enterprise Value$1.54B
Total Cash (Recent Filing)$232.43M
Total Debt (Recent Filing)$75.57M
Price to Earnings (P/E)―
Beta2.22
Next Earnings
Jan 30, 2026EPS Estimate
-0.43Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.45
Shares Outstanding61,148,026
10 Day Avg. Volume1,263,242
30 Day Avg. Volume1,623,284
Financial Highlights & Ratios
PEG Ratio0.34
Price to Book (P/B)3.56
Price to Sales (P/S)4.47
P/FCF Ratio-22.25
Enterprise Value/Market Cap0.78
Enterprise Value/Revenue4.10
Enterprise Value/Gross Profit8.08
Enterprise Value/Ebitda-29.57
Forecast
1Y Price Target
$38.00Price Target Upside46.15% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Market OpportunityThere is a strong 'DNA Synthesis and Protein Solutions' guide which suggests that high-teens-plus top-line growth is still intact as the company continues to penetrate large and growing end-markets.
Strategic PositioningTwist’s platform provides advantages in cost, speed, and quality, positioning it well to capture share as diagnostics companies scale test volumes.
Technological AdvantageTwist Bioscience's proprietary silicon chip technology provides advantages in cost, speed, and scale.
Bears Say
Growth ConcernsShares closed down 10% with the debate centering on whether the guide is reflective of the bear case, indicating a deceleration in growth potential.
Guidance ShortfallThe company's 2026 guidance for revenue and gross margin is below what analysts had expected.
Revenue Mix PressureShares of TWST have been under pressure due to questions raised by revenue mix assumptions in FY26 guidance despite FQ4 topline revs actually beating guidance.
Twist Bioscience News
TWST FAQ
What was Twist Bioscience’s price range in the past 12 months?
Twist Bioscience lowest stock price was $23.30 and its highest was $55.33 in the past 12 months.
What is Twist Bioscience’s market cap?
Twist Bioscience’s market cap is $1.98B.
When is Twist Bioscience’s upcoming earnings report date?
Twist Bioscience’s upcoming earnings report date is Jan 30, 2026 which is in 48 days.
How were Twist Bioscience’s earnings last quarter?
Twist Bioscience released its earnings results on Nov 14, 2025. The company reported -$0.45 earnings per share for the quarter, missing the consensus estimate of -$0.415 by -$0.035.
Is Twist Bioscience overvalued?
According to Wall Street analysts Twist Bioscience’s price is currently Undervalued.
Does Twist Bioscience pay dividends?
Twist Bioscience does not currently pay dividends.
What is Twist Bioscience’s EPS estimate?
Twist Bioscience’s EPS estimate is -0.43.
How many shares outstanding does Twist Bioscience have?
Twist Bioscience has 61,148,026 shares outstanding.
What happened to Twist Bioscience’s price movement after its last earnings report?
Twist Bioscience reported an EPS of -$0.45 in its last earnings report, missing expectations of -$0.415. Following the earnings report the stock price went down -10.134%.
Which hedge fund is a major shareholder of Twist Bioscience?
Currently, no hedge funds are holding shares in TWST
Twist Bioscience Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$38.00 (46.15% Upside)
$38.00 (46.15% Upside)
Blogger Sentiment
Neutral
TWST Sentiment 50%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 326.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 0.5%
Last 30 Days ▲ 7.2%
Last 30 Days ▲ 7.2%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-36.34%
12-Months-Change
Fundamentals
Return on Equity
-16.43%
Trailing 12-Months
Asset Growth
4.48%
Trailing 12-Months
Company Description
Twist Bioscience
Twist Bioscience is a biotechnology company that specializes in synthetic DNA production and gene synthesis. Founded in 2013 and headquartered in San Francisco, California, the company operates primarily in the life sciences sector and serves various industries including pharmaceuticals, agriculture, and industrial biotechnology. Twist Bioscience's core products include synthetic genes, gene fragments, and other DNA-based products, which are utilized in research, development, and manufacturing processes.
TWST Company Deck
TWST Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Twist Bioscience reported strong financial performance with record revenue and significant margin improvement, driven by growth in SynBio, Biopharma, and NGS segments. However, the transition of a major customer and moderate growth guidance for fiscal 2026 presents challenges. The company is optimistic about future growth driven by AI-enabled discovery and new product introductions.View all TWST earnings summariesTWST Stock 12 Month Forecast
Average Price Target
$38.00
▲(46.15% Upside)
Technical Analysis
Ownership Overview
Currently, No data available
---